3623 results for «2067»
3623 results
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
 
                The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
 
                Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...
 
                Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease
28 Nov 2022 – From PCR London Valves 2022
Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.
 
                TAVI: new devices and procedural refinements
27 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!
 
                Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
 
                Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
 
                TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
 
                TMVR challenges
27 Nov 2022 – From PCR London Valves 2022
Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!
 
                TAVI complications: Session 1
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of challenging TAVI complications cases: an annular rupture after TAVI in a bicuspid aortic valve, an outflow tract rupture during self-expandable transcatheter valve implantation, a periprocedural TAVI ischaemic stroke, and more!
 
                TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
 
                Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
 
                CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.
 
                Rapid-fire clinical cases: Session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 case submissions in this session: quadricuspid aortic valve with pure regurgitation treated with Evolut PRO, complex high-risk patient with severe aortic regurgitation and extra-large anatomy, snare-assisted TAVI in case of calcified sinotubular junction, and more!
 
                Rapid-fire abstracts: session 3
27 Nov 2022 – From PCR London Valves 2022
Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.
 
                Rapid-fire abstracts: session 2
27 Nov 2022 – From PCR London Valves 2022
Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.
 
                HighLife TSMVR and their latest experiences, moving forward
29 Nov 2022 – From PCR London Valves 2022
A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.
 
                PCR's Got Talent - Round 1 - Session 1
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: DAPT modulation after PCI for ACS, plaque burden assessment from OCT with deep learning, prognosis of myocardial infarction in patients with cancer, and much more!
 
                PCI in complex high-risk patients: acute coronary syndrome and multivessel disease PCI
19 May 2022 – From EuroPCR 2022
Consider an 86-year-old man with acute chest pain and history of HTN, HLP, DM, renal insufficiency, peripheral artery disease, PTA, urocystic cancer, and TIA, and discuss how to treat this very complex patient combining all the problems we face every day in one person.
 
                PCI in acute coronary syndrome: when do we need assist device?
19 May 2022 – From EuroPCR 2022
Take the case of a 70-year-old-patient suffering obesity, DM, HTN, HLD, who presented with an anterior STEMI and shock, or the one of a 74-year-old woman with ACS and a very low ejection fraction, and get to understand when assist devices can be used.
 
                 
                     
                    